Nobo Medicine
Seongdong
About Nobo Medicine
Genome Opinion develops clinical-level drugs driven by novel biomarkers.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $27.6M
- Funding stage: Late Stage Venture
- Last round: Non-Equity Assistance (Feb 2018)
- Website: genomeopinion.com
- Phone: 82 2-6215-6200
Industries & Categories
Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/nobo-medicine-966566 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.